Wostyn Peter, De Deyn Peter Paul
Department of Psychiatry, PC Sint-Amandus, 8730 Beernem, Belgium.
Laboratory of Neurochemistry & Behavior, Institute Born-Bunge, University of Antwerp, Department of Biomedical Sciences, 2610 Antwerp, Belgium.
Biomark Med. 2017 Nov;11(11):1003-1008. doi: 10.2217/bmm-2017-0218. Epub 2017 Sep 4.
A significant proportion of the astronauts who spend extended periods in microgravity develop ophthalmic abnormalities. Understanding this syndrome, called visual impairment and intracranial pressure (VIIP), has become a high priority for National Aeronautics and Space Administration, especially in view of future long-duration missions (e.g., Mars missions). Moreover, to ensure selection of astronaut candidates who will be able to complete long-duration missions with low risk of the VIIP syndrome, it is imperative to identify biomarkers for VIIP risk prediction. Here, we hypothesize that the optic nerve sheath response to alterations in intracranial pressure may be a potential predictive biomarker for optic disc edema in astronauts. If confirmed, this biomarker could be used for preflight identification of astronauts at risk for developing VIIP-associated optic disc edema.
在微重力环境中长时间停留的宇航员中有很大一部分会出现眼部异常。了解这种被称为视觉障碍和颅内压(VIIP)的综合征,已成为美国国家航空航天局的当务之急,特别是考虑到未来的长期任务(如火星任务)。此外,为确保选拔出能够在低VIIP综合征风险下完成长期任务的宇航员候选人,必须识别用于VIIP风险预测的生物标志物。在此,我们假设视神经鞘对颅内压变化的反应可能是宇航员视盘水肿的潜在预测生物标志物。如果得到证实,这种生物标志物可用于飞行前识别有发生VIIP相关视盘水肿风险的宇航员。